Stereocomplex Prodrugs of Oligo(lactic acid)n-Gemcitabine in Poly(ethylene glycol)-block-poly(d,l-lactic acid) Micelles for Improved Physical Stability and Enhanced Antitumor Efficacy
- 29 June 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 12 (7) , 7406-7414
Abstract
Herein we demonstrate the formation of stereocomplex prodrugs of oligo(l-lactic acid)n-gemcitabine (o(LLA)n-GEM) and oligo(d-lactic acid)n-gemcitabine (o(DLA)n-GEM) for stable incorporation in poly(ethylene glycol)-block-poly(d,l-lactic acid) (PEG-b-PLA) micelles. O(LLA)n or o(DLA)n was attached at the amino group (4-(N)) of GEM via an amide linkage. When n = 10, a 1:1 mixture of o(LLA)10-GEM and o(DLA)10-GEM (o(L+DLA)10-GEM) was able to form a stereocomplex with a distinctive crystalline pattern. Degradation of o(L+DLA)10-GEM was driven by both backbiting conversion and esterase contribution, generating primarily o(L+DLA)1-GEM and GEM. O(L+DLA)10-GEM stably loaded in PEG-b-PLA micelles in the size range of 140–200 nm with an unexpected elongated morphology. The resulting micelles showed improved physical stability in aqueous media and inhibited backbiting conversion of o(L+DLA)10-GEM within micelles. Release of o(L+DLA)10-GEM from micelles was relatively slow, with a t1/2 at ca. 60 h. Furthermore, weekly administration of o(L+DLA)10-GEM micelles i.v. displayed potent antitumor activity in an A549 human non-small-cell lung carcinoma xenograft model. Thus, stereocomplexation of isotactic o(LLA)n and o(DLA)n acts as a potential prodrug strategy for improved stability and sustained drug release in PEG-b-PLA micelles.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (R01AI01157)
This publication has 26 references indexed in Scilit:
- Gemcitabine versus Modified Gemcitabine: A Review of Several Promising Chemical ModificationsMolecular Pharmaceutics, 2012
- Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancerNanomedicine: Nanotechnology, Biology and Medicine, 2011
- Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micellesBiomaterials, 2011
- Stereocomplexed Poly(lactic acid)−Poly(ethylene glycol) Nanoparticles with Dual-Emissive Boron Dyes for Tumor AccumulationACS Nano, 2010
- Liposomal squalenoyl-gemcitabine: formulation, characterization and anticancer activity evaluationNanoscale, 2010
- Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)Annals of Oncology, 2010
- Stable Dispersions of Highly Anisotropic Nanoparticles Formed by Cocrystallization of Enantiomeric Diblock CopolymersMacromolecules, 2007
- Biodegradable dextran hydrogels crosslinked by stereocomplex formation for the controlled release of pharmaceutical proteinsInternational Journal of Pharmaceutics, 2004
- Biopolymer stereocomplexesAdvanced Drug Delivery Reviews, 2003
- Monodisperse Enantiomeric Lactic Acid Oligomers: Preparation, Characterization, and Stereocomplex FormationMacromolecules, 1998